Metabolite profiling of fecal water extracts from human colorectal cancer
暂无分享,去创建一个
Daniel Monleón | Bernardo Celda | D. Monleón | B. Celda | J. M. Morales | José Manuel Morales | Antonio Barrasa | Jose Antonio López | Carlos Vázquez | A. Barrasa | José Antonio Quintana López | Carlos Vázquez
[1] D. Evans,et al. Molecular stool screening for colorectal cancer , 2004, The British journal of surgery.
[2] J. Lovegrove,et al. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. , 2006, Current medicinal chemistry.
[3] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[4] J. Jass,et al. Altered mucin expression in the gastrointestinal tract: a review , 2001, Journal of cellular and molecular medicine.
[5] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[6] Elaine Holmes,et al. Metabonomics in pharmaceutical R & D , 2007, The FEBS journal.
[7] J. Nicholson,et al. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. , 2003, The Analyst.
[8] A. Evdokiou,et al. Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. , 2000, Carcinogenesis.
[9] D. Ahlquist,et al. Stool markers for colorectal cancer screening: future considerations. , 1996, Digestive diseases.
[10] L. Martí-Bonmatí,et al. Metabolite identification in human liver needle biopsies by high‐resolution magic angle spinning 1H NMR spectroscopy , 2006, NMR in biomedicine.
[11] S. Lewis,et al. Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.
[12] H. Frederiksen,et al. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. , 2005, Molecular nutrition & food research.
[13] Kirill Veselkov,et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. , 2008, Journal of proteome research.
[14] K. Kinzler,et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.
[15] J. Lupton,et al. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. , 1992, Cancer research.
[16] D. Palli,et al. Fecal Levels of Short-Chain Fatty Acids and Bile Acids as Determinants of Colonic Mucosal Cell Proliferation in Humans , 2002, Nutrition and cancer.
[17] R. Dubrow,et al. Fecal protein markers of colorectal cancer. , 1992, The American journal of gastroenterology.
[18] C. Wagener,et al. Detection of K‐ras mutations in stools of patients with colorectal cancer by mutant‐enriched PCR , 1996, International journal of cancer.
[19] Constance M. Johnson,et al. Screening for Colorectal Cancer: A Comparison of 3 Fecal Occult Blood Tests , 1997 .
[20] Henrik Antti,et al. Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids. , 2002, The Analyst.
[21] S. Schreiber,et al. Fiber-derived butyrate and the prevention of colon cancer. , 1997, Chemistry & biology.
[22] M. Tanner,et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Ochiai,et al. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples. , 2002, International journal of oncology.
[24] A. Rebecchi,et al. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. , 1996, Gastroenterology.
[25] Mark R. Viant,et al. Improved classification accuracy in 1- and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation , 2007, BMC Bioinformatics.
[26] B. Evers,et al. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells , 2002, Gut.
[27] L. Martí-Bonmatí,et al. 1H and 13C HR‐MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas , 2004, NMR in biomedicine.
[28] T. Walle. Absorption and metabolism of flavonoids. , 2004, Free radical biology & medicine.
[29] C. Paraskeva,et al. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[30] R. Bresalier,et al. Mucins and mucin binding proteins in colorectal cancer , 2004, Cancer and Metastasis Reviews.
[31] R. Dubrow,et al. Fecal lysozyme: an unreliable marker for colorectal cancer. , 1992, The American journal of gastroenterology.
[32] D. Ahlquist,et al. Stool screening for colorectal cancer: molecular approaches. , 2005, Gastroenterology.
[33] S. Gendler,et al. Epithelial mucin genes. , 1995, Annual review of physiology.
[34] P. Pouillart,et al. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies. , 1998, Life sciences.
[35] T. Kanematsu,et al. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer , 1996, Cancer.
[36] L. Påhlman,et al. Screening for colorectal cancer , 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[37] S. Bingham,et al. Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer , 1990, Proceedings of the Nutrition Society.
[38] L. Garfinkel,et al. U.S. cancer incidence, mortality and survival: 1973-1996. , 1999, Statistical bulletin.
[39] P. Vos,et al. Standardization for transcriptomic molecular markers to screen human colon cancer. , 2007, Cancer genomics & proteomics.
[40] I. Wilson,et al. Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.
[41] L M Schuman,et al. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. , 1989, Gastroenterology.
[42] Yonggoo Kim,et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. , 2003, Annals of clinical and laboratory science.
[43] I. Wilson,et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.
[44] S. Batra,et al. Structural organization and classification of the human mucin genes. , 2001, Frontiers in bioscience : a journal and virtual library.
[45] L. Ferguson,et al. Dietary fibres as "prebiotics": implications for colorectal cancer. , 2005, Molecular nutrition & food research.
[46] G. Rechkemmer,et al. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. , 1999, Carcinogenesis.
[47] C. Probert,et al. Mucins in the gastrointestinal tract in health and disease. , 2001, Frontiers in bioscience : a journal and virtual library.
[48] E. Vaughan,et al. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome , 2008, NMR in biomedicine.
[49] D. Monleón,et al. Determination of metabolite concentrations in human brain tumour biopsy samples using HR‐MAS and ERETIC measurements , 2009, NMR in biomedicine.
[50] W. Bodmer,et al. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. , 1995, Gut.
[51] D. Monleón,et al. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. , 2008, Journal of proteome research.
[52] I. Hirata,et al. Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases. , 2007, World journal of gastroenterology.